[an error occurred while processing this directive]

Hereditas(Beijing) ›› 2026, Vol. 48 ›› Issue (11): 1085-1097.doi: 10.16288/j.yczz.26-145

• Research Article • Previous Articles     Next Articles

Mechanistic study on the role of lamprey NATTERIN in ameliorating hyperlipidemia by regulating cardiac lipid transport and metabolism

Zeyu Du1,2(), Shixi Sun1,2, Yujie Qiu1,2, Yue Pang1,2()   

  1. 1 College of Life Science, Liaoning Normal University, Dalian 116081, China
    2 Lamprey Research Center, Liaoning Normal University, Dalian 116081, China
  • Received:2026-06-16 Revised:2026-10-13 Online:2026-11-20 Published:2026-10-23
  • Contact: Yue Pang E-mail:duzeyu@lnnu.edu.cn;pangyue01@163.com
  • Supported by:
    National Natural Science Foundation of China(32070518);National Natural Science Foundation of China(32470558);Applied Basic Research Project of the Science and Technology Department of Liaoning Province(XLYC2002093);Project of the Educational Department of Liaoning Province(JTYQN2023268);Project of the Educational Department of Liaoning Province(JYTMS20231060);Dalian Youth Science and Technology Star Fund Project(2022RQ041)

Abstract:

Hyperlipidemia is a major risk factor for cardiovascular diseases. As an extant jawless vertebrate, lampreys possess a unique physiological system that reflects the ancestral features of lipid metabolism in vertebrates. To explore whether this system harbors novel lipid-lowering bioactive molecules applicable to the treatment of hyperlipidemia, we first performed a multi-tissue comparative transcriptomic analysis and identified a set of heart-specific genes in the lamprey, among which NATTERIN was found to be upregulated in response to adrenaline. Using a transgenic zebrafish model overexpressing NATTERIN, we observed that NATTERIN promoted cardiac lipid enrichment and reduced lipid accumulation in peripheral blood vessels. Transcriptomic analysis further revealed significant upregulation of lipid transport- and metabolism-related genes, including the cardiac-type fatty acid-binding protein FABP3, as well as PPARα and PGC1α. Conversely, in lamprey embryos in which NATTERIN was silenced by siRNA, the fatty acid metabolic pathway was markedly suppressed, with reduced expression of PPARα and PGC1α. Furthermore, an acute hyperlipidemia model was established in Lethenteron reissneri using Tyloxapol. Following treatment with recombinant NATTERIN protein, plasma levels of triglycerides, total cholesterol, and low-density lipoprotein cholesterol were significantly decreased, while those of high-density lipoprotein cholesterol were elevated. Concurrently, the expression of PPARα, PGC1α, and other fatty acid metabolism-related genes was upregulated in the heart, with free fatty acid content returning to normal levels. Collectively, these findings demonstrate that NATTERIN activates the expression of cardiac lipid transport and metabolism genes, including FABP3, PGC1α, and PPARα, thereby enhancing fatty acid catabolism and promoting the clearance of lipids from peripheral blood vessels by the heart, and provide an evolutionary perspective for the development of new therapeutic strategies against hyperlipidemia.

Key words: lamprey, NATTERIN, heart, fatty acid metabolism, hyperlipidemia